Get started
CrayonTwin 0.382 retracement coinciding with a channel support line. Crayon has a habit of extending 1.618 of previous run before a correction (wave 3 = x1.618 wave 1), ranging back to 2018. If these extensions were applied to Wave 3 and to Wave 1→ peak Wave 3 and with a target being the channel resistance it would lead to a target somewhere within the red bubble in early 2021. Wave 1 and Wave 3 have an almost identical % rise (128.2% and 126.9% respectively). If these % gains were applied to wave
C
by gpiugpuubh
Photocure Long (retracement first)The whole stock market is experiencing the same type of "crack" as it did back in Feb/March, now being fueled by a Covid second wave and uncertainty around the US elections. Photocure's RSI is approaching its year low levels in March. The down period in March lasted for about 1 month. The length of this down period will be more uncertain depending on the outcome of the election. Regardless, I see Photocure retracing to between 71 and no more than 57NOK (which would equal a retracement of 0.786,
OSL:PHOLong
by electricalTuna1995
9
#SoftOx closer to a possible breakthrough against #covid19The Danish Medicines Agency has given its recommendation for further development of the SoftOx inhalation solution for the treatment of respiratory infections, including COVID-19. The SoftOx Inhalation Project aims to develop an inhalation solution for the treatment of respiratory infections. This has the potential to be a breakthrough in the treatment of respiratory infections including Covid-19 infections. Following a scientific advisory meeting with the Danish Medicines Agency, a favorable d
OSL:SOFTX
by savepiginvest
ArcticZymes $AZT Q3 2020 reportHighlights for Q3 2020 • Annual group sales exceed 100 MNOK for the first time • Gross profit for the Group improved 65% to NOK 26.0 million (Q3 2019: NOK 15.7 million) • ArcticZymes had Q3 sales of NOK 19.5 million growing by 63% (Q3 2019: NOK 12.0 million) • Biotec BetaGlucans had Q3 sales of NOK 11.2 million growing by 7% (Q3 2019: NOK 10.5 million) • Upsides relating to COVID-19 pandemic is estimated at NOK 4 million for ArcticZymes and NOK 1.25 million for consumer health • The Group deliv
OSL:AZT
by savepiginvest
1
Lifecare Long (daughter company worth 4x as much)This analysis isn't as based on techincal indicators as it is on market insight. As far as the technical signs go, RSI and stochastic RSI show that it is significantly underbought. The appearance of an ascending triangle formation is also noticable, with high potential gains if it breaks up. The most interesting find is that Lifecare has ownership in Digital Diagnostics (a company which has come far within Covid-19 testing) worth over 4x as much as the Lifecare valuation itself. This coupled wit
OSL:LIFELong
by electricalTuna1995
Ultimovacs Announces Updated Positive Results from Phase I TrialOslo, 19 October 2020: Ultimovacs ASA ("Ultimovacs", ticker ULTIMO), today announced five-year overall survival data from the Phase I trial evaluating UV1 as maintenance therapy in patients with non-small cell lung cancer. The results confirm achievement of the primary endpoints of safety and tolerability and indicate encouraging initial signals of long-term survival benefit. "Ultimovacs has established a growing body of clinical data demonstrating a strong safety and tolerability profile for
ULong
by savepiginvest
NODL long, short-term MAs moving up. Northern drilling seems to have bottomed out after an extended devaluation period. The stock has oscillated between 3 and 6 NOK for the past months and looks to have entered a bullish channel. Technical signals include a recent 10 and 20 MA crossing up in the 4 hour and 1 day intervals. The stock's potential ability to break out over its resistance levels at 5 and 6.7 NOK could indicate a longer bullish trend. Stochastic RSI and RSI indicate that the instrument is close to or overbought as of no
NLong
by electricalTuna1995
Norwegian Air shuttle's potential - stock price down 99.72%Hello you all As you know Norwegian Air Shuttle is a company which is heavely affected by the actual pandemic. So why could the stock have a huge potential in the near/medium term future? - Chinese government invested via BOC Aviation into Norwegian - cash burn reduced to <300 million NOK per month - current stock price 99.72% under all time high Norwegian announced at the beginning of the pandemic, that there will be a liquidity risk from Q4 2020/Q1 2021. Norwegian is currently talking with t
OSL:NASLong
by iTsTricky
10
Norwgian Air Shuttle (NAS)"The time to buy is when there's blood in the streets." - Baron Rothschild So if you are looking for said blood the Norwegian Air shuttle (NAS) might be worth a serious look. Background: Biggest airline company in Scandinavia. One of the biggest in the world (I believe Top 6). It's based in Norway. Norway is a rich country. "Oil rich". Like many other airline companies the company is suffering massive losses. The state of Norway has already helped the company out a lot. Pros: As just mentione
OSL:NAS
by FourApplesADay
2
PCI Biotech $PCIB bullish breaching 100EMA coming into Q4* Norwegian Drug Delivery Platform Biotech operating within the Oslo Cancer Cluster * Notoriously volatile norwegian small cap with large amount of stock held by enthusiastic retail investor crowd. * Ongoing research collaboration with AstraZeneca recently concluded, longs betting on partnership deal incoming. * Stock typically rallies ahead of quarterly reports and experiences sell the news events. * Norwegian biotech flying at All Time High valuations after recent Vaccibody partnership with Ge
PLong
by savepiginvest